Eucrates Biomedical Acqui...

NASDAQ: EUCRU · Real-Time Price · USD
10.02
-0.07 (-0.69%)
At close: Apr 26, 2023, 9:59 PM

Eucrates Biomedical Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
18.86K 49.16K
Short-Term Investments
12.35M n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
12.35M 104.84M
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
n/a 215K
Total Current Assets
132.2K 264.16K
Property-Plant & Equipment
n/a n/a
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
12.35M 104.84M
Total Assets
12.49M 105.11M
Account Payables
n/a n/a
Deferred Revenue
n/a n/a
Short-Term Debt
n/a n/a
Other Current Liabilities
65.14K n/a
Total Current Liabilities
65.14K 38.46K
Long-Term Debt
n/a n/a
Other Long-Term Liabilities
3.88M n/a
Total Long-Term Liabilities
3.88M 5.76M
Total Liabilities
3.95M 5.8M
Total Debt
60.06K n/a
Common Stock
12.25M 104.8M
Retained Earnings
-3.72M -5.49M
Comprehensive Income
n/a n/a
Shareholders Equity
8.54M 99.31M
Total Investments
12.35M n/a